Geographic variation in pharmacotherapy decisions for U.S. medicare enrollees with diabetes

Journal of Diabetes and its Complications

Volumn 26, Issue 4, 2012, Pages 301-307

  Sargen, Michael R ^a   Hoffstad, Ole J ^a   Wiebe, Douglas J ^a   Margolis, David J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Diabetes treatment; Ethnicity; Gender; Geographic variation in diabetes care; Medicare; Metformin; Race

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; BIGUANIDE; INSULIN; METFORMIN; SULFONYLUREA;

AFRICAN AMERICAN; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; ETHNICITY; FEMALE; GEOGRAPHIC DISTRIBUTION; HISPANIC; HUMAN; INCOME; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICARE; PRIORITY JOURNAL; RACE; SEX DIFFERENCE; UNITED STATES;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; BIGUANIDES; DEMOGRAPHY; DIABETES MELLITUS, TYPE 2; DRUG THERAPY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; INCOME; INSULINS; LINEAR MODELS; MALE; MEDICARE; RETROSPECTIVE STUDIES; SULFONYLUREA COMPOUNDS; THIAZOLIDINEDIONES; UNITED STATES;

EID: 84863778097     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2012.04.001     Document Type: Article

References (32)

1. Alexander, G. C., Sehgal, N. L., Moloney, R. M., & Stafford, R. S. (2008). National trends in treatment of type 2 diabetes mellitus, 1994-2007. Archives of Internal Medicine, 168, 2088-2094.
2. Ashkenazy, R., & Abrahamson, M. J. (2006). Medicare coverage for patients with diabetes. A national plan with individual consequences. Journal of General Internal Medicine, 21, 386-392.
3. Bonds, D. E., Miller, M. E., Bergenstal, R. M., et al. (2010). The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ, 340, b4909.
4. Cohen, F. J., Neslusan, C. A., Conklin, J. E., & Song, X. (2003). Recent antihyperglycemic prescribing trends for US privately insured patients with type 2 diabetes. Diabetes Care, 26, 1847-1851. (Pubitemid 36929131)
5. DeFronzo, R. A., & Goodman, A. M. (1995). Efficacy of metformin in patients with noninsulin- dependent diabetes mellitus. The Multicenter Metformin Study Group. New England Journal of Medicine, 333, 541-549.
6. Desai, N. R., Shrank, W. H., Fischer, M. A., et al. (2012). Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications. American Journal of Medicine, 125, 302.e1-302.e7.
7. Desouza, C., Salazar, H., Cheong, B., Murgo, J., & Fonseca, V. (2003). Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring. Diabetes Care, 26, 1485-1489. (Pubitemid 36929183)
8. Economic costs of diabetes in the U.S. in 2007. Diabetes Care, 31. (2008)., 596-615.
9. Escobedo, J., Rana, J. S., Lombardero, M. S., et al. (2010). Association between albuminuria and duration of diabetes and myocardial dysfunction and peripheral arterial disease among patients with stable coronary artery disease in the BARI 2D study. Mayo Clinic Proceedings, 85, 41-46.
10. Harris, M. I., Eastman, R. C., Cowie, C. C., Flegal, K. M., & Eberhardt, M. S. (1999). Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care, 22, 403-408. (Pubitemid 29106894)
11. Havard, S., Deguen, S., Zmirou-Navier, D., Schillinger, C., & Bard, D. (2009). Trafficrelated air pollution and socioeconomic status: a spatial autocorrelation study to assess environmental equity on a small-area scale. Epidemiology, 20, 223-230.
12. Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. (2008). 10-year follow-up of intensive glucose control in type 2 diabetes. New England Journal of Medicine, 359, 1577-1589.
13. Home, P. D., Pocock, S. J., Beck-Nielsen, H., et al. (2007). Rosiglitazone evaluated for cardiovascular outcomes-an interim analysis. New England Journal of Medicine, 357, 28-38. (Pubitemid 47026732)
14. Huizinga, M. M., Roumie, C. L., Elasy, T. A., et al. (2007). Changing incident diabetes regimens: a Veterans Administration cohort study from 2000 to 2005. Diabetes Care, 30, e85. (Pubitemid 47219445)
15. Ismail-Beigi, F., Moghissi, E., Tiktin, M., Hirsch, I. B., Inzucchi, S. E., & Genuth, S. (2011). Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials. Annals of Internal Medicine, 154, 554-559.
16. Margolis, D. J., Malay, D. S., Hoffstad, O. J., et al. (2011a). Economic burden of diabetic foot ulcers and amputations: data points #3.
17. Margolis, D. J., Malay, D. S., Hoffstad, O. J., et al. (2011b). Incidence of diabetic foot ulcer and lower extremity amputation among Medicare beneficiaries, 2006 to 2008: data points #2.
18. Margolis, D. J., Malay, D. S., Hoffstad, O. J., et al. (2011c). Prevalence of diabetes, diabetic foot ulcer, and lower extremity amputation among Medicare beneficiaries, 2006 to 2008: data points #1.
19. Nathan, D. M. (2002). Clinical practice. Initial management of glycemia in type 2 diabetes mellitus. New England Journal of Medicine, 347, 1342-1349.
20. Nathan, D. M., Buse, J. B., Davidson, M. B., et al. (2006). Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 29, 1963-1972. (Pubitemid 44156663)
21. National Diabetes Statistics, 2011. NIH Publication No. 11-3892.
22. Niefeld, M. R., Braunstein, J. B., Wu, A. W., Saudek, C. D., Weller, W. E., & Anderson, G. F. (2003). Preventable hospitalization among elderly Medicare beneficiaries with type 2 diabetes. Diabetes Care, 26, 1344-1349. (Pubitemid 36929161)
23. Nissen, S. E., & Wolski, K. (2007). Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. New England Journal of Medicine, 356, 2457-2471. (Pubitemid 46919772)
24. Selvin, E., & Erlinger, T. P. (2004). Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation, 110, 738-743. (Pubitemid 39056275)
25. Spatial Autocorrelation. Elsevier, 2009. (Accessed December 16, 2011, 2009, at, http://www.elsevierdirect.com/brochures/hugy/SampleContent/Spatial- Autocorrelation.pdf.).
26. Stratton, I. M., Adler, A. I., Neil, H. A., et al. (2000). Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ, 321, 405-412. (Pubitemid 30609442)
27. Tsai, P. J., Lin, M. L., Chu, C. M., & Perng, C. H. (2009). Spatial autocorrelation analysis of health care hotspots in Taiwan in 2006. BMC Public Health, 9, 464.
28. UK Prospective Diabetes Study (UKPDS) Group. (1998). Effect of intensive bloodglucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet, 352, 854-865.
29. Whitmer, R. A., Karter, A. J., Yaffe, K., Quesenberry, C. P., Jr., & Selby, J. V. (2009). Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. Journal of the American Medical Association, 301, 1565-1572.
30. Woodcock, J., Sharfstein, J. M., & Hamburg, M. (2010). Regulatory action on rosiglitazone by the U.S. Food and Drug Administration. New England Journal of Medicine, 363, 1489-1491.
31. Zammitt, N. N., & Frier, B. M. (2005). Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care, 28, 2948-2961. (Pubitemid 43942931)
32. Zoungas, S., Patel, A., Chalmers, J., et al. (2010). Severe hypoglycemia and risks of vascular events and death. New England Journal of Medicine, 363, 1410-1418.